FDA inspection

PRA International Group BV: FDA inspection ending Jan 22, 2010

FDA inspection 649582 · Voluntary Action Indicated (VAI) · Assen

Key facts

Inspection ID	649582
Firm	PRA International Group BV
FEI number	3006317816
Address	Westerbrink 3
City	Assen
Fiscal year	2010
Inspection end date	Jan 22, 2010
Classification	Voluntary Action Indicated (VAI)
Project area	Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bio-Research Monit: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs\|Bioresearch Monitoring: Human Drugs
Product type	Drugs

At a glance

None Citations
1–9 Posted citations
No Warning letter followed
Yes Form FDA 483 issued
Yes Establishment inspection report (EIR) exists
1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections